ES2058721T3 - Fenilsulfonamidas iso- y heterociclicas. - Google Patents

Fenilsulfonamidas iso- y heterociclicas.

Info

Publication number
ES2058721T3
ES2058721T3 ES90120150T ES90120150T ES2058721T3 ES 2058721 T3 ES2058721 T3 ES 2058721T3 ES 90120150 T ES90120150 T ES 90120150T ES 90120150 T ES90120150 T ES 90120150T ES 2058721 T3 ES2058721 T3 ES 2058721T3
Authority
ES
Spain
Prior art keywords
iso
phenylsulphonamides
heterociclicas
heterocyclic
thromboxane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90120150T
Other languages
English (en)
Inventor
Ulrich Dr Niewohner
Franz-Peter Dr Hoever
Elisabeth Dr Perzborn
Volker-Bernd Dr Fiedler
Peter Dr Norman
Hilary P Dr Francis
Marie G Dr Mckenniff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Application granted granted Critical
Publication of ES2058721T3 publication Critical patent/ES2058721T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/17—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/92—Naphthopyrans; Hydrogenated naphthopyrans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
    • C07C2603/24—Anthracenes; Hydrogenated anthracenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
    • C07C2603/26—Phenanthrenes; Hydrogenated phenanthrenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

ISOPOR LA REACCION DE LA CORRESPONDIENTE ISO CON DERIVADOS DE ACIDO FENILSULFANICO. LOS ISOFENILSULFAMIDAS TIENEN AGREGACION-INHIBICION DE TROMBOCITOS Y LA ACCION ANTAGONISTA DE TROMBOXANE A SUB 2 Y PUEDEN SER USADOS EN MEDICAMENTOS.
ES90120150T 1989-11-02 1990-10-20 Fenilsulfonamidas iso- y heterociclicas. Expired - Lifetime ES2058721T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898924755A GB8924755D0 (en) 1989-11-02 1989-11-02 Iso-and heterocyclic phenylsulphonylamides

Publications (1)

Publication Number Publication Date
ES2058721T3 true ES2058721T3 (es) 1994-11-01

Family

ID=10665616

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90120150T Expired - Lifetime ES2058721T3 (es) 1989-11-02 1990-10-20 Fenilsulfonamidas iso- y heterociclicas.

Country Status (9)

Country Link
US (1) US5191092A (es)
EP (1) EP0425946B1 (es)
JP (1) JPH03153661A (es)
AT (1) ATE110066T1 (es)
CA (1) CA2029057A1 (es)
DE (1) DE69011620T2 (es)
DK (1) DK0425946T3 (es)
ES (1) ES2058721T3 (es)
GB (1) GB8924755D0 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0528762B1 (de) * 1991-08-15 1997-05-07 Novartis AG N-Acyl-N-Heterocyclyl- oder Naphthylalkyl-Aminosäuren als Angiotensin II Antagonisten
US7368582B2 (en) * 2003-10-17 2008-05-06 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 2-(4-sulfonylamino)-3-hydroxy-3,4-dihydro-2H-chromen-6-yl compounds, a process and intermediates for their production, and pharmaceutical compositions containing them
JP2012500189A (ja) * 2008-08-15 2012-01-05 エフ．ホフマン−ラ ロシュ アーゲー ビアリールアミノテトラリン
CA2734104A1 (en) * 2008-08-15 2010-02-18 F. Hoffmann-La Roche Ag Substituted aminotetralines
CN106905248B (zh) * 2017-01-20 2021-07-16 贵州医科大学 川芎嗪并环类化合物、其药物组合物及在药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3623941A1 (de) * 1986-07-16 1988-01-28 Bayer Ag Substituierte amino-5,6,7,8-tetrahydronaphthyl-oxyessigsaeuren, verfahren zu deren herstellung sowie die verwendung als arzneimittel
DE3642105A1 (de) * 1986-12-10 1988-06-16 Bayer Ag Substituierte aminomethyl-5,6,7,8-tetrahydronaphtyl-oxyessigsaeuren, neue zwischenprodukte, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE3737195A1 (de) * 1987-11-03 1989-05-18 Bayer Ag Chromanderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln

Also Published As

Publication number Publication date
DE69011620D1 (de) 1994-09-22
JPH03153661A (ja) 1991-07-01
DE69011620T2 (de) 1994-12-15
US5191092A (en) 1993-03-02
EP0425946A3 (en) 1991-10-23
ATE110066T1 (de) 1994-09-15
EP0425946B1 (en) 1994-08-17
GB8924755D0 (en) 1989-12-20
DK0425946T3 (da) 1994-12-12
EP0425946A2 (en) 1991-05-08
CA2029057A1 (en) 1991-05-03

Similar Documents

Publication Publication Date Title
NO2002009I2 (no) Tiotropium
DK415089D0 (da) Fremgangsmaade til suspensionspolymerisation i et organisk medium
DE69029141D1 (de) Angioplastie mit niedrigem physiologischen stress
DE3886768D1 (de) Vorrichtung zum herstellen von kunststoff-formteilen und verwendung der vorrichtung.
DE3885832D1 (de) Prüfkopfmanipulator mit verbesserter Aufhängung.
DE3864895D1 (de) Modifizierter dienpolymerkautschuk.
ATE88183T1 (de) Substituierte 4-(chinolin-2-yl-methoxy)phenylessigs|ure-derivate.
DE3678784D1 (de) Vinylmonomere und kristalline fluessige polymerderivate.
DE3850338D1 (de) Spritzgiessvorrichtung zum Herstellen von Kunststoffgegenständen.
ATA212488A (de) Maschinenschraubstock mit kraftverstaerker
PT86785A (pt) Novel naphthalene derivatives having use as antiallergy and antiinflammatory agents
DK584388D0 (da) Polymerkomposition
NO881534L (no) Nye karbapenem-forbindelser.
DK404789A (da) Nye antiarrytmiske midler i
DE69026324D1 (de) Regler mit zwei Freiheitsgraden
DE69022778D1 (de) Zellkultursubstrat, Bioreaktor mit Zellkultursubstrat und therapeutische Vorrichtung vom extrakorporalen Umlauftyp.
DK0425946T3 (da) Iso- og heterocycliske phenylsulfonamider
FI881264A0 (fi) Kääntövarsilaite
DE68913672D1 (de) N-substituierte Maleimid-Herstellungsverfahren.
DE3779091D1 (de) Polyalkoholpolymer.
NO892728L (no) Aminoalkyl-aminokarbonyl-aminodiolaminosyre derivater somanti-hypertensive midler.
DE3881270D1 (de) Verwendung von pyrrolidon-derivaten als antiamnetikum.
DE3683469D1 (de) Fluessigkeitsgelagerte inertiale messvorrichtung mit zwei freiheitsgraden.
DE69025112D1 (de) Verstärkerschaltung mit zwei Invertern
DE68906630D1 (de) Leckfreie kupplungsvorrichtung von zwei behaeltern.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 425946

Country of ref document: ES